Background Image
Table of Contents Table of Contents
Previous Page  16 / 40 Next Page
Information
Show Menu
Previous Page 16 / 40 Next Page
Page Background

Chemical Technology • October 2015

14

Adapting valve designs

to meet industry’s exacting

requirements

I

n sterile process engineering, such as in the production of

insulin, vitamin enzymes or APIs (Active Pharmaceutical

Ingredients highly potent agents), users place special de-

mands on the hygienic valves that they use. This is particularly

apparent in the exacting requirements regarding the produc-

tion process and the materials. There is a noticeable trend

here: “Operators are continually demanding higher quality

materials. In the pharmaceutical sector, stainless steel grades

such as 1.4435 are usually used. However, users are increas-

ingly requesting 1.4359 and Hastelloy qualities,” reported

Alfred Knöbl, product manager of the SISTO-C series at SISTO

Armaturen SA Echternach, Luxembourg. “This is because

these materials are far more corrosion-resistant. The valves

are not necessarily affected by the cleaning liquids used in

the CIP/SIP processes, but rather by fluids that are needed

for product processing, for example after fermentation.”

In old systems a lack of space was a common problem

and it is also an issue in new biotech systems. This has given

rise to the present trend of building production facilities in an

increasingly compact way, often grouping together multiple

valves as valve manifolds. As a result, many valve manifolds

are frequently installed under the tanks. Froma hygiene point

of view, this new design offers nothing but advantages, as

Knöbl explained: “The compact design reduces the neces-

sary distances between the valves and eliminates dead legs

in the piping.”

Another trend that has an impact on the production pro-

cess is the increasing use of very small nominal diameters.

Typical nominal diameters used in the pharmaceutical sector

range from DN 8 to DN 50; most are between DN 15 and

DN 20. However, valves with a nominal diameter of DN 2 are

also needed sometimes. “These are not laboratory applica-

tions,” clarified Knöbl. “Producing such nominal diameters is

a big challenge in terms of the production process.” For this

reason, in addition to establishing new production processes

at SISTO, the necessary measuring methods and quality

monitoring systems were also set up.

Very low flow rates are also needed in processingmethods

such as chromatography, for example. Another particularity:

these applications require a very high compressive strength in

some cases and operating pressures of 20bar are quite usual.

“In normal pharmaceutical production we have operating

Hygienic diaphragm valves are needed

for a wide variety of applications in the

pharmaceutical and biotech sector.

Having paved the way for reliable aseptic

production with its unique design years

ago, the SISTO-C series is continually

adapted to meet industry’s increasingly

stringent requirements.

by Bryan Orchard